✦ LIBER ✦

Idarubicin in combination with cytarabine and VP-16 in the treatment of post-MDS AML patients

✍ Scribed by Pogliani, E.M.; Baldicchi, L.; Pioltelli, P.; Miccolis, I.R.; Mangiagalli, M.; Corneo, G.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

174 Intensive chemotherapy (idarubicin,

✍ A. Ganser; W.K. Hofmann; G. Geissler; O.G. Ottmann; J.Th. Fischer; G. Heil; W. H 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Use of cytarabine and idarubicin in a ne

✍ Humeyra Bozoglan; Ulku Ergene; Levent Yoleri 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Prognostic significance of alterations i

✍ Farhad Ravandi; Keyur Patel; Rajyalakshmi Luthra; Stefan Faderl; Marina Konoplev 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 954 KB

Idarubicin in combination with intermedi

✍ Angelo M. Carella; Ester Pungolino; Gabriella Piatti; Eugenia Gaozza; Sandro Nat 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

9242 Pharmacogenetic factors in metaboli

✍ Seeringer, A.; Yi-Jing, H.; Schlenk, R.; Doehner, K.; Doehner, H.; Kirchheiner, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

510 Addition of All-Trans Retinoic Acid

✍ Asifa Malik; Carlos Bueso-Ramos; Stefan Faderl; Eli Estey; Susan O'Brien; Michae 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 153 KB